INTESTINAL PERFUSION AND PERMEABILITY IN SEPSIS
脓毒症的肠道灌注和渗透性
基本信息
- 批准号:2178851
- 负责人:
- 金额:$ 21.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1987
- 资助国家:美国
- 起止时间:1987-04-01 至 1996-03-31
- 项目状态:已结题
- 来源:
- 关键词:adenylate kinase allopurinol antioxidants bacterial disease biopsy blood toxicology cytoskeleton disease /disorder model endotoxins free radical scavengers gastrointestinal circulation gastrointestinal epithelium gastrointestinal toxin absorption intercellular connection intestinal mucosa ischemia lipopolysaccharides membrane permeability microelectrodes myeloperoxidase oxygen tension radiotracer septic shock swine
项目摘要
It has been hypothesized that derangements in the barrier function of the
gut predispose critically ill patients to the development of bacteremia,
fungemia, and endotoxicosis. The integrity of the epithelial barrier can
be assessed by measuring its permeability to certain water-soluble
compounds, such as 51Cr-EDTA. The permeability of the gut epithelium to
hydrophilic solutes is determined by the functional status of the
intercellular tight junctions (zonula occludens; ZO). Recent data suggest
that the ZO is anatomically and functionally linked to the cytoskeleton.
Other results indicate that the organizational integrity of the
cytoskeleton depends upon the maintenance of adequate intracellular levels
of ATP. Since both cellular hypoxia and oxidant stress can interfere with
ATP synthesis, we have hypothesized that lipopolysaccharide (LPS)-induced
mucosal hyperpermeability is caused by ATP depletion in enterocytes.
Accordingly, we will investigate ischemia- and oxidant-induced mucosal ATP
depletion as mechanisms for the adverse effect of endotoxin on gut
epithelial permeability. The proposed studies will utilize a porcine
endotoxicosis model that satisfactorily reproduces many of the hemodynamic
manifestations of septic shock in resuscitated patients. Mucosal
permeability will be quantitated by measuring the plasma-to-lumen clearance
of 51Cr-EDTA. Mucosal oxygenation will be measured using a multiwire
Clark-type surface electrode array that permits the monitoring of 02
tensions in multiple microscopic hemispheres (radius~20 uM) of tissue.
Using these methods, we will assess the time-dependent effects of LPS on
mucosal oxygenation, ATP content, and permeability. In addition, we will
determine whether LPS-induced mucosal hyperpermeability can be prevented by
maintaining normal epithelial oxygenation, either by pump-perfusing the
vascular supply of the gut with oxygenated blood or perfusing the lumen of
the gut with oxygenated buffer. Also, we will investigate the role of
oxidants by assessing the effects of allopurinol (a xanthine oxidase
inhibitor) or oxygen free-radical scavengers of mucosal permeability and
ATP content in endotoxic animals. Finally, we will assess the affects of
mucosal hypoxia or oxidant stress on mucosal ATP content and permeability
in normal pigs. These studies should provide new insights into the
mechanisms responsible for mucosal hyperpermeability in sepsis and
endotoxicosis.
有人假设,在屏障功能的紊乱,
肠道使重症患者易于发生菌血症,
真菌血症和内毒素中毒。 上皮屏障的完整性可以
通过测量其对某些水溶性物质的渗透性来评估
化合物,如51 Cr-EDTA。 肠上皮细胞对
亲水性溶质的功能状态取决于
细胞间紧密连接(闭锁小带; ZO)。 最近的数据表明
ZO在解剖学和功能上与细胞骨架相连。
其他结果表明,组织的完整性,
细胞骨架依赖于维持足够的细胞内水平
的ATP。 由于细胞缺氧和氧化应激都可以干扰
ATP合成,我们假设脂多糖(LPS)诱导的
粘膜通透性过高是由肠上皮细胞中的ATP耗竭引起的。
因此,我们将研究缺血和氧化诱导的粘膜ATP
消耗作为内毒素对肠道的不利影响的机制
上皮通透性 拟议的研究将使用猪
内毒素中毒模型,令人满意地再现了许多血流动力学
在复苏的病人中感染性休克的表现。 粘膜
将通过测量血浆-管腔清除率来定量渗透性
51Cr-EDTA 将使用多导丝测量粘液氧合
允许监测O2的Clark型表面电极阵列
组织的多个微观半球(半径约20 μ M)中的张力。
使用这些方法,我们将评估LPS对细胞的时间依赖性影响。
粘膜氧合、ATP含量和渗透性。 此外,我们会
确定是否可以通过以下方法预防LPS诱导的粘膜通透性过高:
维持正常的上皮氧合,或者通过泵灌注
用含氧血液或灌注肠腔的血管供应
用含氧缓冲液清洗肠道 此外,我们还将研究
通过评估别嘌呤醇(一种黄嘌呤氧化酶)
抑制剂)或氧自由基清除剂,
内毒素动物体内ATP含量。 最后,我们将评估
粘膜缺氧或氧化应激对粘膜ATP含量和通透性的影响
正常的猪。 这些研究应该提供新的见解,
脓毒症中粘膜通透性过高的机制,
内毒素中毒
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mitchell P. Fink其他文献
Effects of nonsteroidal anti-inflammatory drugs on renal function in septic dogs.
非甾体抗炎药对脓毒症犬肾功能的影响。
- DOI:
10.1016/0022-4804(84)90135-5 - 发表时间:
1984 - 期刊:
- 影响因子:0
- 作者:
Mitchell P. Fink;Thomas J. MacVittie;Larry C. Casey - 通讯作者:
Larry C. Casey
Postoperative complications in patients with disabling psychiatric illnesses or intellectual handicaps. A case-controlled, retrospective analysis.
患有致残性精神疾病或智力障碍的患者的术后并发症。
- DOI:
10.1001/archsurg.1990.01410230030005 - 发表时间:
1990 - 期刊:
- 影响因子:0
- 作者:
B. Cutler;Mitchell P. Fink - 通讯作者:
Mitchell P. Fink
Biology of heterotrimeric G-protein signaling.
异源三聚体 G 蛋白信号传导生物学。
- DOI:
- 发表时间:
2000 - 期刊:
- 影响因子:8.8
- 作者:
R. Forse;John M. Luce;Michael B. Yaffe;Mitchell P. Fink - 通讯作者:
Mitchell P. Fink
Hemorrhagic Ascites: An Unusual Presentation of Primary Splenic Lymphoma
- DOI:
10.1016/s0016-5085(82)80346-6 - 发表时间:
1982-08-01 - 期刊:
- 影响因子:
- 作者:
Joseph F. Hacker;Joel E. Richter;Robert S. Pyatt;Mitchell P. Fink - 通讯作者:
Mitchell P. Fink
CRISIS IN CRITICAL CARE The Demand for Critical Care Services is Increasing Critical care
重症监护危机 对重症监护服务的需求正在增加 重症监护
- DOI:
- 发表时间:
2005 - 期刊:
- 影响因子:0
- 作者:
David T. Huang;T. Osborn;K. Gunnerson;Scott R. Gunn;Stephen Trzeciak;Edward Kimball;Mitchell P. Fink;De Angus;R. Dellinger;Emanuel P. Rivers - 通讯作者:
Emanuel P. Rivers
Mitchell P. Fink的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mitchell P. Fink', 18)}}的其他基金
MOLECULAR BASIS FOR EPITHELIAL BARRIER DYSFUNCTION/PROJECT 2
上皮屏障功能障碍的分子基础/项目 2
- 批准号:
6829217 - 财政年份:2004
- 资助金额:
$ 21.36万 - 项目类别:
Ethyl Pyruvate: A Novel Treatment for Sepsis
丙酮酸乙酯:脓毒症的新型治疗方法
- 批准号:
6765286 - 财政年份:2003
- 资助金额:
$ 21.36万 - 项目类别:
Ethyl Pyruvate: A Novel Treatment for Sepsis
丙酮酸乙酯:脓毒症的新型治疗方法
- 批准号:
6911508 - 财政年份:2003
- 资助金额:
$ 21.36万 - 项目类别:
Ethyl Pyruvate: A Novel Treatment for Sepsis
丙酮酸乙酯:脓毒症的新型治疗方法
- 批准号:
6669337 - 财政年份:2003
- 资助金额:
$ 21.36万 - 项目类别:
COMPLEMENT-DEPENDENT PROSTAGLANDIN SYNTHESIS IN SEPSIS
脓毒症中补体依赖性前列腺素合成
- 批准号:
3466035 - 财政年份:1987
- 资助金额:
$ 21.36万 - 项目类别:
COMPLEMENT-DEPENDENT PROSTAGLANDIN SYNTHESIS IN SEPSIS
脓毒症中补体依赖性前列腺素合成
- 批准号:
3466038 - 财政年份:1987
- 资助金额:
$ 21.36万 - 项目类别:
COMPLEMENT-DEPENDENT PROSTAGLANDIN SYNTHESIS IN SEPSIS
脓毒症中补体依赖性前列腺素合成
- 批准号:
3466034 - 财政年份:1987
- 资助金额:
$ 21.36万 - 项目类别:
相似国自然基金
Apocynin和allopurinol对运动上调自发性高血压大鼠肾脏一氧化氮合成酶表达的影响
- 批准号:81301667
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Allopurinol Improves Diastolic Function in African Americans with Resistant Hypertension
别嘌呤醇可改善患有难治性高血压的非裔美国人的舒张功能
- 批准号:
10701217 - 财政年份:2023
- 资助金额:
$ 21.36万 - 项目类别:
Association Between Allopurinol and Cardiovascular Events, Mortality and End-Stage Renal Disease in Diabetes
别嘌呤醇与糖尿病心血管事件、死亡率和终末期肾病之间的关联
- 批准号:
377029 - 财政年份:2017
- 资助金额:
$ 21.36万 - 项目类别:
Fellowship Programs
CKD-FIX: a randomised, controlled trial of allopurinol in the slowing of kidney disease progression
CKD-FIX:别嘌呤醇减缓肾脏疾病进展的随机对照试验
- 批准号:
nhmrc : GNT1043203 - 财政年份:2013
- 资助金额:
$ 21.36万 - 项目类别:
Project Grants
PERL: A multi-center clinical trial of allopurinol to prevent GFR loss in T1D
PERL:别嘌呤醇预防 T1D 患者 GFR 损失的多中心临床试验
- 批准号:
9738022 - 财政年份:2013
- 资助金额:
$ 21.36万 - 项目类别:
PERL: A multicenter clinical trial of allopurinol to prevent GFR loss in T1D
PERL:别嘌呤醇预防 T1D 患者 GFR 损失的多中心临床试验
- 批准号:
8644403 - 财政年份:2013
- 资助金额:
$ 21.36万 - 项目类别:
A multicenter clinical trial of allopurinol to prevent GFR loss in T1D
别嘌呤醇预防 1 型糖尿病 GFR 损失的多中心临床试验
- 批准号:
8445008 - 财政年份:2012
- 资助金额:
$ 21.36万 - 项目类别:
Design of a Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
别嘌呤醇预防 1 型糖尿病 GFR 损失的多中心临床试验设计
- 批准号:
8250159 - 财政年份:2011
- 资助金额:
$ 21.36万 - 项目类别:
Analysis of the mechanisms of allopurinol-induced severe cutaneous adverse reactions
别嘌呤醇致严重皮肤不良反应的机制分析
- 批准号:
23790611 - 财政年份:2011
- 资助金额:
$ 21.36万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
ALLOPURINOL AND CARDIAC FUNCTION IN IDIOPATHIC DILATED CARDIOMYOPATHY
特发性扩张型心肌病中别嘌呤醇与心脏功能
- 批准号:
7199117 - 财政年份:2004
- 资助金额:
$ 21.36万 - 项目类别:
ALLOPURINOL AND THE PREVENTION OF DEATH, TISSUE INJURY, AND SEIZURES IN CHD
别嘌呤醇与预防冠心病死亡、组织损伤和癫痫发作
- 批准号:
6116864 - 财政年份:1998
- 资助金额:
$ 21.36万 - 项目类别: